Formerly known as the International AIDS Conference (IAC), the first AIDS event took place in Atlanta in 1985 and was organised by the Centers for Disease Control and Prevention (CDC), the World Health Organisation (WHO), and Emory University. More than 2000 scientists, activists and public health officials came together to share information on HIV and AIDS as an emerging epidemic. Now organised by the International AIDS Society (IAS), the AIDS 2024 conference hosted over 15,000 scientists, healthcare professionals and people living with and affected by HIV to share the latest data and lessons learnt from the HIV response over the past 40 years.

OUR AIDS 2024 HIGHLIGHTS

We invited all members of the HIV community, from HCPs to people living with HIV, to join us at AIDS 2024 in Munich, Germany, from 22-26 July. This conference served as a crucial platform for us to showcase our latest advances in HIV treatment, prevention, and innovation, as well as our long-standing partnership with the HIV community. As ever, the dynamic and vibrant atmosphere in the global village was a highlight of the conference, and it was amazing to see everyone there.

See our highlights from AIDS 2024

PARTNERING WITH THE COMMUNITY

We are always proud to showcase our enduring commitment to the HIV community, whether that is through our 30+ year Positive Action Programme, or through our digital campaigns where we continue to collaborate as partners, advocates, and champions to address the issues that matter most.

Here were just some of our activities:

  • HIV Science as Art Exhibition

    Organised by Müncher Aidshilfe, the first regional AIDS aid organisation in Germany. We were proud to be the exclusive supporters of HIV Science as Art, a groundbreaking exhibition merging the talents of 12 artists living with HIV with 12 scientists across the globe.

  • ViiV Sponsored Symposium

    On 23 July, AIDS 2024 delegates joined our Patient Engagement team in an unconventional symposium, “How do we genuinely change the dynamics and put ‘People First’?” where we highlighted the importance of people-partnered care in HIV.

  • Community event

    AIDS 2024 delegates and our partners who were in Munich came to join us for a community event focussed on how we would end the HIV epidemic. This event brought together people from across the HIV ecosystem, including local community groups, scientists , activists, and policymakers.

  • Positive Action booth

    Over the course of AIDS 2024, our Positive Action booth in the Global Village hosted a series of informal sessions open to all attendees of the congress, on a range of topics including:

    • Digital storytelling
    • Building an online-community to educate and tackle stigma related to HIV
    • The importance of grassroots community-led advocacy
    • Collaborative approaches to HIV care in Germany

To find out more about upcoming conferences and events, click here.

OUR ULTIMATE GOAL: TO END THE HIV EPIDEMIC

At ViiV healthcare, our goal is ambitious, yet clear: we want to end the HIV epidemic. We believe we have the tools to achieve this goal through continuous innovation, talented people and global partnerships that help us reach the communities that are disproportionately impacted by HIV. We must keep investing in the global HIV response.

There’s a misconception that HIV Is a solved problem- it is not, and remains a significant global health challenge. But with collaboration, driven by deep community engagement and strategic partnerships, we move one step closer to ending the epidemic.

For people living with HIV. Resources and information about living well with HIV.

For news and media. Latest news and press releases via our media centre.

For healthcare professionals, Information about ViiV medicines and data.

NP-GBL-HVX-COCO-240034 | July 2024

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the GSK Reporting Tool link https://gsk.public.reportum.com/. By reporting side effects, you can help provide more information on the safety of this medicine.

If you are from outside the UK, you can report adverse events to GSK/ ViiV by selecting your region and market, here.